MSD wins FDA approval for cholesterol pill to help plug Keytruda void
MSD has outpaced rivals to market the first PCSK9 inhibitor in pill form for patients with high cholesterol.
MSD has outpaced rivals to market the first PCSK9 inhibitor in pill form for patients with high cholesterol.
With 89% of AI pilots failing to scale, biopharmas can move from data skepticism to advocacy by building a trusted, globally harmonized foundation. By Sebastian Wurst, Director of OpenData Strategy,...
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Keeping pace with generative AI in pharmaceutical and healthcare organisations
Pharma Meets AI Conference 2026: Key barriers to scaling AI in drug development
Advancing pressure protection in biopharma: how integrated bypass technology elevates single-use pump design
CinnaGen Enters EU Market with EMA Approval for Zandoriah®